Background illustration for clinical trials search

Paid Clinical Trials Orlando

Discover 1,033 paid clinical trials in Orlando, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Orlando FL, Tampa FL, Gainesville FL, Jacksonville FL,
Sponsor: Children's Oncology Group

Sex: Female

Age: 0 - 39

Code: NCT06513962

Phase 3, Recruiting

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

for
Multiple Sclerosis (MS) Primary Progressive
Location: Orlando FL, Maitland FL, Tampa FL, Bradenton FL,
Sponsor: Zenas BioPharma (USA), LLC

Sex: All

Age: 18 - 60

Code: NCT07067463

Phase 3, Recruiting

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

for
Neuroendocrine Tumors Unresectable,
Location: Orlando FL, Jacksonville FL, Miami FL, Chapel Hill NC,
Sponsor: Perspective Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05636618

Phase 1, Phase 2, Recruiting

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

for
Urothelial Carcinoma Bladder,
Location: Orlando FL, Tampa FL, Miami FL, Glen Burnie MD,
Sponsor: Aktis Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07020117

Phase 1, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Orlando FL, St. Petersburg FL, Fort Myers FL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

for
Squamous Cell Carcinoma of Head and Neck
Location: Orlando FL, St. Petersburg FL, Fort Myers FL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07276399

Phase 3, Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: Orlando FL, St. Petersburg FL, Gainesville FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase 3, Recruiting

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: Orlando FL, Tampa FL, Charleston SC, Atlanta GA,
Sponsor: AVEO Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06064877

Phase 3, Recruiting

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

for
Biliary Tract Cancer
Location: Orlando FL, Louisville KY, Toronto, Portland OR
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06282575

Phase 3, Recruiting

Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

for
Proliferative Diabetic Retinopathy (PDR)
Location: Orlando FL, Lakeland FL, Tampa FL, Jacksonville FL,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18+

Code: NCT06790784

Phase 3, Recruiting

Using a mHealth Intervention to Promote Physical Activity in Phase III Cardiac Rehabilitation Clients

for
Cardiac Rehabilitation, Physical Activity
Location: Orlando FL
Sponsor: AdventHealth University

Sex: All

Age: 18 - 70+

Code: NCT05795036

Recruiting

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

for
Lupus Nephritis
Location: Orlando FL, Kissimmee FL, Jacksonville FL, Margate FL,
Sponsor: Aurinia Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07611214

Recruiting

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

for
FSGS
Location: Orlando FL, Miami FL, Atlanta GA, Charlotte NC,
Sponsor: Dimerix Bioscience Pty Ltd

Sex: All

Age: 12 - 70+

Code: NCT05183646

Phase 3, Recruiting

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

for
Diabetic Kidney Disease (DKD)
Location: Orlando FL, Port Orange FL, Port Saint Lucie FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07271186

Phase 2, Recruiting

Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

for
Primary Membranous Nephropathy
Location: Orlando FL, Winter Park FL, Miami FL, Columbus GA,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07204275

Phase 2, Phase 3, Recruiting

PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease

for
Proteinuric Kidney Diseases
Location: Orlando FL, Riverview FL, Boca Raton FL,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 12+

Code: NCT07355296

Phase 2, Recruiting

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

for
Glomerulonephritis, IGA, Immunoglobulin A Nephropathy
Location: Orlando FL, Lawrenceville GA, Birmingham AL,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06797518

Phase 2, Recruiting

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

for
Focal Segmental Glomerulosclerosis
Location: Orlando FL, Riverview FL, Port Charlotte FL,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 12+

Code: NCT07220083

Phase 3, Recruiting

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

for
Immunoglobulin A Nephropathy (IgAN)
Location: Orlando FL, Gainesville FL, Bradenton FL,
Sponsor: Biogen

Sex: All

Age: 18+

Code: NCT06935357

Phase 3, Recruiting

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

for
Solid Tumor
Location: Orlando FL, Miami FL, Myrtle Beach SC, Durham NC,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT06874335

Phase 1, Recruiting

Orlando, Florida has a well-developed healthcare system with several prominent medical research facilities, making it an important hub for a diverse array of clinical trials. Notable institutions such as the Orlando Health Cancer Institute and the University of Central Florida's College of Medicine are at the forefront of these research initiatives.

Each medical center in Orlando focuses on innovative studies across various fields, including oncology, cardiovascular health, and neurological disorders, positioning Orlando as a vital contributor in advancing medical research and treatment options.

Why choose Orlando for clinical trials?

Orlando offers a vast array of advantages for individuals considering participation in clinical trials. The city is home to a diverse population, which helps create a wide range of participants, enhancing the reliability and applicability of research findings.

Additionally, Orlando’s thriving healthcare ecosystem fosters an environment of innovation and collaboration, with a strong emphasis on advancing medical research and treatment. By participating in a clinical trial in Orlando, participants not only gain access to innovative therapies but also play a crucial role in advancing scientific knowledge.

Common conditions studied in Orlando

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Orlando